Published: September 28, 2015

InSphero Granted Hanging Drop Patent in the United States

InSphero Granted Hanging Drop Patent in United States

Schlieren, Switzerland, September 29, 2015 – Patent establishes protection of InSphero GravityPLUSTM technology in all major global markets, key milestone for leading provider of 3D cell culture platforms, microtissues and services.  

The United States Patent and Trademark Office (USPTO) officially granted InSphero AG full protection of its GravityPLUSTM hanging drop technology. InSphero, the world's leading developer of easy-to-use solutions for organotypic 3D cell culture models and body-on-a-chip systems, now holds hanging drop patents in the world's major pharmaceutical and biotechnology markets, including the United States, Europe, China, Japan, and Singapore. The core patent WO2010031194 describes multi-well plates which allow the generation of hanging drops for 3D cel culture, using convenient top loading of the cell suspension.

InSphero commercialized the hanging drop technology as the GravityPLUS™ Hanging Drop System in 2010. The system includes the GravityPLUS™ plate used for production of 3D spheroids in hanging drops, and also the companion GravityTRAP™ culture and assay plate, to which 3D microtissues are transferred for long-term culture and drug testing.

Dr. Jan Lichtenberg, CEO and co-founder of InSphero, says that the favorable decision has been a long time coming for InSphero. “We are excited the USPTO has recognized the originality of our design, and granted protection of the investment we have made into the creation of new technology. This protection allows us to operate unhindered in the US market, gives our customers the added confidence to invest in InSphero technology as their platform of choice for 3D cell culture, and provides the grounds necessary to defend against industry competitors attempting to imitate our technology.”

Granting of the patent on September 8 followed InSphero’s recent completion of a Series C financing round and August announcement naming PerkinElmer as the exclusive global distributor of InSphero hanging drop and ultra-low attachment (ULA) plates for 3D cell culture.

InSphero Granted Hanging Drop Patent in the United States

Other News

News

InSphero and PharmaNest Form a Partnership to Advance Translational Fibrosis Research 

InSphero has entered a strategic partnership with PharmaNest Inc to advance the translational assessment of fibrosis in human-relevant 3D in vitro models. By combining advanced 3D liver spheroids with high-resolution, AI-enabled digital pathology, the collaboration aims to enable quantitative, phenotype-resolved analysis of fibrotic remodeling and improve the prediction of therapeutic efficacy in complex fibrotic diseases.

Read More »
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource